lunes, 27 de octubre de 2014

UPDATE 2-Merck beats profit forecast with deep cost cuts

(Adds CEO, analyst comment, cancer drug special designation)



















from Reuters: Company News http://ift.tt/1DjRfBz

via IFTTT

No hay comentarios:

Publicar un comentario